ACCENDRA HEALTH INC/VA/ — Form 8-K/A
Filed September 28, 2026 · analyzed by the 8-K Agent
8-K/A
▼ Likely negative
significance 72/100
What the filing says
Edward A. Pesicka resigned as CEO effective October 5, 2026, and converted to independent contractor through March 31, 2029. Pesicka receives COBRA subsidy (18 months) and continued equity vesting; must execute broad release of claims and remains bound by non-compete/non-solicit covenants with tolled post-service restrictions. No cash separation amount disclosed.
Why this rating
CEO departure is material governance event; extended paid consulting + equity retention reduces clean break but indicates potential instability. Relative to $677.5M market cap, financial cost modest but leadership continuity risk is real.
Price action (we called it negative)
before filing · preread $0.65 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.